Quick Takeaways
- Anson Funds Management LP filed SCHEDULE 13G/A for Oncolytics Biotech, Inc. Common Stock, no par value (ONCY).
- Disclosed ownership: 7%.
- Date of event: 30 Sep 2025.
Anson Funds Management LP - 30 Sep 2025 SCHEDULE 13G/A Report for Oncolytics Biotech, Inc. Common Stock, no par value (ONCY)
- Filing Manager
- Anson Funds Management LP
- Reporting Manager
- Anson Funds Management LP
- Symbol
- ONCY
- Shares outstanding
- 109,272,143 shares
- Disclosed Ownership
- 7,649,050 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 15:05:03 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Anson Funds Management LP disclosed 7% ownership in Oncolytics Biotech, Inc. Common Stock, no par value (ONCY) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 14 Nov 2025, 15:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (6)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Anson Funds Management LP | 7% | 7,649,050 | 0 | 7,649,050 | /s/ Tony Moore | Tony Moore, Manager | |
| Anson Management GP LLC | 7% | 7,649,050 | 0 | 7,649,050 | /s/ Tony Moore | Tony Moore, Manager | |
| Tony Moore | 7% | 7,649,050 | 0 | 7,649,050 | /s/ Tony Moore | Tony Moore, Manager | |
| Anson Advisors Inc. | 7% | 7,649,050 | 0 | 7,649,050 | /s/ Amin Nathoo | Amin Nathoo, Director | |
| Amin Nathoo | 7% | 7,649,050 | 0 | 7,649,050 | /s/ Amin Nathoo | Amin Nathoo, Director | |
| Moez Kassam | 7% | 7,649,050 | 0 | 7,649,050 | /s/ Moez Kassam | Moez Kassam, Director |